A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Clinical trial NCT00729872 · COMPLETED

Trial details

NCT number: NCT00729872
Sponsor: ActoGeniX N.V.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Moderately Active Ulcerative Colitis

Start date: 2008-07-01
Primary completion: 2009-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.